SCHEMBL6889818

SCHEMBL6889818

NC(=S)c1ccc([N+](=O)[O-])cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.54
ADRA2B P18089 2/20 0.54
ADRA2C P18825 2/20 0.54
SLC2A1 P11166 1/20 0.46
GAA P10253 2/20 0.45
CYP1A2 P05177 1/20 0.45
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 7/20 0.42
LMNA P02545 4/20 0.42
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX12 P18054 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
P4HTM Q9NXG6 1/20 0.41
PLAU P00749 1/20 0.41
KDM4E B2RXH2 1/20 0.41
AGTR1 P30556 1/20 0.41
NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL41111 0.84 ADRA2A (0.56) ADRA2AADRA2BADRA2CSLC2A1GAA
SCHEMBL18827493 0.82 CYP1A2 (0.53) ADRA2AADRA2BADRA2CSLC2A1GAA
Methane SCHEMBL28217937 0.82 ADRA2A (0.54) ADRA2AADRA2BADRA2CSLC2A1GAA
SCHEMBL27722370 0.79 ADRA2A (0.51) ADRA2AADRA2BADRA2CSLC2A1GAA
SCHEMBL17365240 0.78 ADRA2A (0.46) ADRA2AADRA2BADRA2CSLC2A1GAA
SCHEMBL9098551 0.78 P4HTM (0.61) ADRA2AADRA2BADRA2CSLC2A1GAA
SCHEMBL1403645 0.78 P4HTM (0.61) ADRA2AADRA2BADRA2CSLC2A1GAA
SCHEMBL5326143 0.76 ALDH1A1 (0.53) ADRA2AADRA2BADRA2CSLC2A1GAA
SCHEMBL6163873 0.76 CYP1A2 (0.58) ADRA2AADRA2BADRA2CSLC2A1GAA
Hydrochloric Acid SCHEMBL28862169 0.76 P4HTM (0.60) ADRA2AADRA2BADRA2CSLC2A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004110351-A2 HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS ANADYS PHARMACEUTICALS, INC. (US) 2004-12-23 WO disclosed